BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6263540)

  • 21. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 22. [Captopril-a new principle in the treatment of hypertension].
    Forslund T; Fyhrquist F
    Tidsskr Nor Laegeforen; 1981 Aug; 101(23):1290-2. PubMed ID: 7022744
    [No Abstract]   [Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Successful treatment of severe refractory hypertension with captopril].
    Gabizon D; Weissgarten Y; Pik A; Modai D
    Harefuah; 1981 Oct; 101(7-8):167-9. PubMed ID: 6277749
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renin-angiotensin system blocking drugs in the diagnosis and treatment of arterial hypertension].
    Kabat M; Makowiecka-Cieśla M
    Kardiol Pol; 1984; 27(2):147-57. PubMed ID: 6328092
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of perindopril and amiloride/hydrochlorothiazide on haemodynamics and vessel wall properties of large arteries.
    Kool MJ; Lustermans FA; Breed JG; Struyker-Boudier HA; Hoeks AP; Van Bortel LM
    J Hypertens Suppl; 1993 Dec; 11(5):S362-3. PubMed ID: 8158423
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current clinical use of converting enzyme inhibitors].
    Corvol P; Plouin PF; Castaigne A; Palsky E
    Rev Prat; 1982 Jan; 32(1):75-82. PubMed ID: 6275488
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combination captopril-hydrochlorothiazide in a single dose for treatment of essential arterial hypertension].
    Forattini C; Perin S
    Riv Eur Sci Med Farmacol; 1988 Feb; 10(1):63-7. PubMed ID: 3079199
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of essential arterial hypertension in the elderly with low-dose captopril and hydrochlorothiazide. Long-term study].
    Aranda-Lara P; Gras-Balaguer X; Cabello M; Martín-Reyes G; Valera A; Frutos M; López de Novales E
    Rev Clin Esp; 1987 Sep; 181(4):185-9. PubMed ID: 3313556
    [No Abstract]   [Full Text] [Related]  

  • 37. Captopril in mild and moderate essential hypertension: physiological and biochemical monitoring.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand Suppl; 1983; 677():105-9. PubMed ID: 6322529
    [No Abstract]   [Full Text] [Related]  

  • 38. Captopril for hypertension.
    Med Lett Drugs Ther; 1980 May; 22(9):39-40. PubMed ID: 6245345
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy and safety of low doses of captopril, alone or associated with diuretics, in the treatment of mild and moderate hypertension].
    Hatab SA; dos Santos AG
    Arq Bras Cardiol; 1984 Apr; 42(4):305-9. PubMed ID: 6391437
    [No Abstract]   [Full Text] [Related]  

  • 40. [Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
    Ocón J; Oliván J; Garrido Peralta M; Ruilope L; Rodicio JL; Seco Vasco J; Rodríguez Alvarez J; Gras X
    Med Clin (Barc); 1985 Nov; 85(15):617-21. PubMed ID: 3908851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.